We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Future cancer immunotherapy trials need new standardized endpoints and evaluation criteria, regulators and scientists said at an FDA workshop. Read More
The federal government is looking for a partner to collaborate on developing a new treatment for anxiety and depression based on a chemical by-product produced when the body breaks down the drug ketamine. Read More